comparemela.com

Latest Breaking News On - William hoffman - Page 5 : comparemela.com

Inari Medical (NASDAQ:NARI) PT Lowered to $55.00 at Canaccord Genuity Group

Inari Medical (NASDAQ:NARI) PT Lowered to $55.00 at Canaccord Genuity Group
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
William-hoffman
Piper-sandler
Mitchc-hill
Brown-advisory-inc
Wells-fargo-company
Vanguard-group-inc
Fuller-thaler-asset-management-inc
Inari-medical-inc
Needham-company
Canaccord-genuity-group
Norges-bank

Inari Medical (NASDAQ:NARI) PT Lowered to $57.00 at Needham & Company LLC

Inari Medical (NASDAQ:NARI – Free Report) had its price objective cut by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. NARI has been the topic of a number of other reports. Piper Sandler downgraded shares of Inari […]

United-states
William-hoffman
Handelsinvest-investeringsforvaltning
Piper-sandler
Mitchc-hill
Canaccord-genuity-group
Securities-exchange-commission
Needham-company
Benjaminf-edwards-company-inc
Nisa-investment-advisors
Fifth-third-bancorp
Third-bancorp

Inari Medical (NASDAQ:NARI) Given New $57.00 Price Target at Needham & Company LLC

Inari Medical (NASDAQ:NARI – Free Report) had its price target lowered by Needham & Company LLC from $72.00 to $57.00 in a report issued on Wednesday, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. NARI has been the subject of several other research reports. Piper Sandler lowered Inari Medical […]

United-states
Mitchc-hill
Handelsinvest-investeringsforvaltning
William-hoffman
Piper-sandler
Nisa-investment-advisors
Needham-company
Inari-medical-inc
Benjaminf-edwards-company-inc
Fifth-third-bancorp
Canaccord-genuity-group
Securities-exchange-commission

Inari Medical (NASDAQ:NARI) PT Lowered to $84.00 at Wells Fargo & Company

Inari Medical (NASDAQ:NARI – Free Report) had its target price lowered by Wells Fargo & Company from $100.00 to $84.00 in a report released on Wednesday morning, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. Several other analysts have also commented on the stock. Canaccord Genuity Group reaffirmed a […]

United-states
Mitchc-hill
William-hoffman
Handelsinvest-investeringsforvaltning
Piper-sandler
Benjaminf-edwards-company-inc
Inari-medical-company-profile
Fifth-third-bancorp
Inari-medical-inc
Canaccord-genuity-group
Securities-exchange-commission
Needham-company

vimarsana © 2020. All Rights Reserved.